| 注册
首页|期刊导航|亚太传统医药|中药干预非编码RNA治疗肝癌研究进展

中药干预非编码RNA治疗肝癌研究进展

肖婷芬 陈畅 李欣雨 曹俊 赵诗怡 彭媛俊 江星明 王志琪 徐菲

亚太传统医药2025,Vol.21Issue(11):225-231,7.
亚太传统医药2025,Vol.21Issue(11):225-231,7.DOI:10.11954/ytctyy.202511043

中药干预非编码RNA治疗肝癌研究进展

Research Progress of Traditional Chinese Medicine Interfering with Non-Coding RNA for the Treatment of Hepatocellular Carcinoma

肖婷芬 1陈畅 2李欣雨 1曹俊 1赵诗怡 2彭媛俊 2江星明 2王志琪 1徐菲1

作者信息

  • 1. 湖南中医药大学药学院,湖南长沙 410208||湖南中医药大学 中药学国家一流专业建设点,湖南 长沙 410208
  • 2. 湖南中医药大学药学院,湖南长沙 410208
  • 折叠

摘要

Abstract

Non-coding RNAs(ncRNAs)include microRNAs,long-chain non-coding RNAs and cyclic RNAs,is closely related to the development,diagnosis as well as treatment of hepatocellular carcinoma(HCC).And traditional Chinese medicine(TCM)has unique advantages such as multi-targeting and low toxic side effects.Experimental studies have proved that ncRNA can be regulated by Chinese materia medica to inhibit cell proliferation,migration and invasion,pro-mote apoptosis and autophagy,and block the cell cycle of HCC in order to exert its advantages in the treatment of HCC.By reviewing the mechanism of action of ncRNA in HCC treatment,we focus on the mechanism of action of ac-tive ingredients of Chinese materia medica such as flavonoids,alkaloids,polyphenols,triterpenoids,and steroids,as well as extracts and their pairs,in modulating ncRNA for HCC treatment and their biological effects.Therefore,collating and analysing the studies of Chinese materia medica interfering with non-coding RNA for the treatment of hepatocellu-lar carcinoma can provide a theoretical basis for the treatment of HCC with TCM and open up a new way of thinking for drug development and clinical research.

关键词

肝癌/非编码RNA/研究进展/中医药

Key words

Hepatocellular Carcinoma/Non-Coding RNA/Research Progress/Traditional Chinese Medicine

分类

医药卫生

引用本文复制引用

肖婷芬,陈畅,李欣雨,曹俊,赵诗怡,彭媛俊,江星明,王志琪,徐菲..中药干预非编码RNA治疗肝癌研究进展[J].亚太传统医药,2025,21(11):225-231,7.

基金项目

湖南省自然科学基金(2025JJ80130) (2025JJ80130)

湖南省教育厅科学研究优秀青年项目(23B0392) (23B0392)

湖南省中医药科研课题一般项目(B2023010) (B2023010)

湖南省大学生创新训练项目(S202310541084) (S202310541084)

湖南中医药大学重点学科中药学科(校行发规字[2023]2号) (校行发规字[2023]2号)

湖南中医药大学大学本科生科研创新基金项目(2023BKS117) (2023BKS117)

亚太传统医药

1673-2197

访问量0
|
下载量0
段落导航相关论文